Not Logged In

Adamia, Sophia

Name: Adamia, Sophia
Email:
Organization:  
Webpage: none
Interest(s):  
Publications:  
1. S. Adamia, M. Bar-Natan, B. Haibe-Kains, P. Pilarski, C. Bach, S. Pevzner, T. Calimeri, H. Avet-Loiseau, L. Lode, S. Verselis, E. Fox, I. Galinsky, S. Mathews, I. Dagogo-Jack, M. Wadleigh, D. Steensma, G. Motyckova, D. Deangelo, J. Quackenbush, D. Tenen, R. Stone, J. Griffin. "NOTCH2 and FLT3 gene mis-splicing are common events in patients with acute myeloid leukemia (AML): new potential targets in AML". Blood, 123(18), pp 2816–2825, May 2014. view
2. S. Adamia, B. Haibe-Kains, P. Pilarski, M. Bar-Natan, S. Pevzner, H. Avet-Loiseau, L. Lode, S. Verselis, E. Fox, J. Burke, I. Galinsky, I. Dagogo-Jack, M. Wadleigh, D. Steensma, G. Motyckova, D. Deangelo, J. Quackenbush, R. Stone, J. Griffin. "A Genome-wide aberrant RNA splicing in patients with acute myeloid leukemia identifies novel potential disease markers and therapeutic targets". Clinical Cancer Research (CCR), 20(5), pp 1135-1145, March 2014. PDFview
3. S. Adamia, P. Pilarski, M. Bar-Natan, R. Stone, J. Griffin. "Alternative splicing in chronic myeloid leukemia (CML): a novel therapeutic target?". Current Cancer Drug Targets, 13(7), pp 735–748, September 2013. view
4. S. Adamia, P. Pilarski, A. Belch, L. Pilarski. "Aberrant Splicing, Hyaluronan Synthases and Intracellular Hyaluronan as Drivers of Oncogenesis and Potential Drug Targets". Current Cancer Drug Targets, 13(4), pp 347–361, May 2013. view

Author List
University of Alberta Logo AICML Logo